Summary
26 / 100 · Bulios Score
What speaks for it
- Revenue grew by 13% a year over the last 3 years.
- Analysts expect revenue to grow by 113% this fiscal year.
What to watch
- The company made a loss over the last 12 months.
- It missed profit estimates 7 times in the last 8 quarters.
- It passes only 2 of the 9 points of the Piotroski financial health test.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks expensiveThe company made a loss over the last 12 months, so there is no profit to set the price against.
Valuation in detailIs it growing?
Yes, fastRevenue (SEK)
Diluted EPS (SEK)
- Analyst estimate
Revenue grew by 105% a year over 5 years. Over the last 3 years it grew by 13% a year. For the next fiscal year analysts expect revenue to grow by 113%.
Growth in detailDoes it make money?
PoorlyOver the last 12 months it made a loss of 768.2M kr.
Profitability in detailIs it financially healthy?
Debt is a burdenOver the last 12 months it spent more cash than it brought in. Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 1
- Hold 0
- Sell 0
No analyst has published a price target.
100% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
By product
The company reports no revenue by product.
By region
The company reports no revenue by region.